In particular, the positive rate (including high and low expression) of FAP in CRC was 62.6% using the IRS system to quantify the immunohistochemical expression which was different from the 79.1% positivity using the semi-quantitative grading system suggested by Henry et al. [24] (Table 1). The gene discussed is FAP; the disease is colorectal carcinoma.